News

Xiromed LLC Launches Fluorouracil Injection 50mg/mL

August 12, 2021

Florham Park, NJ, August 12, 2021 Xiromed LLC, the New Jersey-based generic division of Insud Pharmaceuticals, today announced the launch of Fluorouracil Injection 50mg/mL, generic to Adrucil®. Annual market sales for Adrucil® and its generics for the twelve-month period ending June, 2021 were $22.2 million, according to IQVIA™.     Xiromed CEO, Narasimhan Mani commented, “The […]


Xiromed LLC Launches Ketoconazole Foam, 2%

August 2, 2021

Florham Park, NJ, August 2, 2021 Xiromed LLC, the New Jersey-based generic division of Insud Pharmaceuticals, today announced the launch of Ketoconazole Foam, 2%, generic to Extina®. “This is an exciting day for Xiromed as we launch our first foam product in the US market.  Xiromed is focused on expanding the range of dosage forms […]


Xiromed LLC Launches Tobramycin Vial for Injection, 1.2g

July 13, 2021

Florham Park, NJ, July 13, 2021 Xiromed LLC, the New Jersey-based generic division of Insud Pharmaceuticals, today announced the launch of Tobramycin Vial for Injection, 1.2g, generic to Nebcin®. Annual market sales for Nebcin® and its generics for the twelve month period ending April, 2021 were $16 million, according to IQVIA™.                   Xiromed CEO, […]


Xiromed LLC Launches Darifenacin ER Tablets

May 5, 2021

Florham Park, NJ, May 5, 2021 Xiromed LLC, the New Jersey-based generic division of Insud Pharmaceuticals, today announced the launch of Darifenacin Extended Release Tablets, generic to Enablex®.  “Xiromed is focused on providing quality generic products to patients in the US and the launch of Darifenacin ER Tablets is the latest example of our commitment […]


Xiromed LLC Launches Omeprazole Delayed Release Capsules, 20mg

March 25, 2021

Florham Park, NJ, March 25, 2021  Xiromed LLC, the New Jersey-based generic division of Insud Pharmaceuticals, today announced the launch of Omeprazole Delayed Release Capsules, 20mg, generic to Prilosec®.  “Xiromed is committed to providing cost effective generic products to our customers, and the launch of Omeprazole Delayed Release Capsules is the latest example of that […]


Xiromed LLC Launches Melphalan Vial for Injection and Progesterone Capsules

March 9, 2021

Florham Park, NJ, March 9, 2021 Xiromed LLC, the New Jersey-based generic division of Insud Pharmaceuticals, announced the launch of Melphalan vial for injection 50mg, generic to Alkeran® and Progesterone capsules, 100mg and 200mg strengths, generic to Prometrium®.   “The launches of Melphalan vial for injection and Progesterone capsules are the latest examples of Xiromed’s commitment […]


Xiromed LLC Launches Gemmily™, First-to-Market Generic to Taytulla®

November 9, 2020

Florham Park, NJ, November 9th, 2020 Xiromed LLC, the New Jersey-based generic division of Insud Pharmaceuticals, today announced the FDA approval of Gemmily™ (Norethindrone Acetate and Ethinyl Estradiol Capsules and Ferrous Fumarate Capsules), 1 mg/20 mcg, a therapeutically equivalent generic version of Taytulla®.  Xiromed is the first generic to Taytulla® approved in the United States.  […]


Xiromed LLC Announces the First Generic Launch of Fosfomycin Tromethamine Granules for Oral Solution, Generic to Monurol®

October 6, 2020

Xiromed LLC today announced the approval and launch of Fosfomycin Tromethamine Granules for Oral Solution, the first AA-rated generic version of Monurol® approved by the U.S. Food and Drug Administration.     Florham Park, NJ – Monurol® (fosfomycin tromethamine) granules for oral solution is a prescription antibiotic approved to treat uncomplicated urinary tract infections (UTI) […]


Xiromed LLC Announces the Launch of Three Generic Injectable Products

August 17, 2020

Xiromed LLC today announced that it has launched the first three injectable products from its strategic collaboration with Gland Pharma Ltd of Hyderabad, India: Irinotecan Injection USP, 20mg/mL, Glycopyrrolate Injection USP, 0.2mg/mL, and Neostigmine Methylsulfate Injection USP, available in two strengths: 5 mg/10 mL (0.5mg/mL) and 10 mg/10 mL (1mg/mL). These are the first injectable […]